{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T02:44:29Z","timestamp":1787798669988,"version":"build-2784847793"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"NIH\/NCI Cancer Center Support Grant","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}]},{"name":"National Cancer Institute of the National Institutes of Health","award":["R25 CA020449"],"award-info":[{"award-number":["R25 CA020449"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1245\/s10434-017-5976-2","type":"journal-article","created":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T09:52:01Z","timestamp":1501581121000},"page":"3048-3054","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Differences Among a Modern Cohort of BRCA Mutation Carriers Choosing Bilateral Prophylactic Mastectomies Compared to Breast Surveillance"],"prefix":"10.1245","volume":"24","author":[{"given":"Elizabeth","family":"Gilbert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily C.","family":"Zabor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Stempel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Mangino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Heerdt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Pilewskie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,1]]},"reference":[{"issue":"5645","key":"5976_CR1","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","volume":"302","author":"MC King","year":"2003","unstructured":"King MC, Marks JH, Mandell JB, New York Breast Cancer Study Group. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science. 2003;302(5645):643-6.","journal-title":"Science."},{"issue":"20","key":"5976_CR2","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199705153362001","volume":"336","author":"JP Struewing","year":"1997","unstructured":"Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, Timmerman MM, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med. 1997;336(20):1401-8.","journal-title":"N Engl J Med."},{"issue":"11","key":"5976_CR3","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","volume":"25","author":"S Chen","year":"2007","unstructured":"Chen S, Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol. 2007;25(11):1329-33.","journal-title":"J Clin Oncol."},{"issue":"11","key":"5976_CR4","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/jnci\/djq202","volume":"102","author":"StatBite","year":"2010","unstructured":"StatBite. BRCA mutations increase risk of breast\/ovarian cancer. J Natl Cancer Inst. 2010;102(11):755","journal-title":"J Natl Cancer Inst"},{"key":"5976_CR5","unstructured":"National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology. BRCA-related breast and\/or ovarian cancer syndrome. Version 2.2017."},{"issue":"1","key":"5976_CR6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jacr.2012.09.036","volume":"10","author":"MB Mainiero","year":"2013","unstructured":"Mainiero MB, Lourenco A, Mahoney MC, Newell MS, Bailey L, Barke LD, et al. ACR appropriateness criteria breast cancer screening. J Am Coll Radiol. 2013;10(1):11-4.","journal-title":"J Am Coll Radiol."},{"issue":"2","key":"5976_CR7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3322\/canjclin.57.2.75","volume":"57","author":"D Saslow","year":"2007","unstructured":"Saslow D, Boetes C, Burke W, Harms S, Leach MO, Lehman CD, Morris E, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57(2):75-89.","journal-title":"CA Cancer J Clin."},{"issue":"4","key":"5976_CR8","first-page":"CD002748","volume":"4","author":"L Lostumbo","year":"2004","unstructured":"Lostumbo L, Carbine N, Wallace J, Ezzo J. Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database Syst Rev. 2004;4(4):CD002748.","journal-title":"Cochrane Database Syst Rev."},{"issue":"2","key":"5976_CR9","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1001\/jama.283.2.202","volume":"283","author":"F Eisinger","year":"2000","unstructured":"Eisinger F, Julian-Reynier C, Sobol H, Stoppa-Lyonnet D, Lasset C, Nogues C. Acceptability of prophylactic mastectomy in cancer-prone women. JAMA. 2000;283(2):202-3.","journal-title":"JAMA."},{"issue":"9","key":"5976_CR10","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1002\/ijc.23340","volume":"122","author":"KA Metcalfe","year":"2008","unstructured":"Metcalfe KA, Birenbaum-Carmeli D, Lubinski J, Gronwald J, Lynch H, Moller P, et al. International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers. Int J Cancer. 2008;122(9):2017-22.","journal-title":"Int J Cancer."},{"issue":"4","key":"5976_CR11","doi-asserted-by":"crossref","first-page":"329-e1","DOI":"10.1016\/j.ajog.2013.01.026","volume":"208","author":"K Singh","year":"2013","unstructured":"Singh K, Lester J, Karlan B, Bresee C, Geva T, Gordon O. Impact of family history on choosing risk-reducing surgery among BRCA mutation carriers. Am J Obstet Gynecol. 2013;208(4):329-e1","journal-title":"Am J Obstet Gynecol."},{"issue":"4","key":"5976_CR12","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1399-0004.2009.01329.x","volume":"77","author":"AB Skytte","year":"2010","unstructured":"Skytte AB, Gerdes AM, Andersen MK, Sunde L, Brondum-Nielsen K, Waldstrom M, et al. Risk-reducing mastectomy and salpingo-oophorectomy in unaffected BRCA mutation carriers: uptake and timing. Clin Genet. 2010;77(4):342-9.","journal-title":"Clin Genet."},{"issue":"7","key":"5976_CR13","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1054\/bjoc.1999.1086","volume":"82","author":"TM Wagner","year":"2000","unstructured":"Wagner TM, Moslinger R, Langbauer G, Ahner R, Fleischmann E, Auterith A, et al. Attitude towards prophylactic surgery and effects of genetic counselling in families with BRCA mutations. Austrian Hereditary Breast and Ovarian Cancer Group. Br J Cancer. 2000;82(7):1249-53.","journal-title":"Br J Cancer."},{"issue":"6","key":"5976_CR14","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1089\/jwh.2016.5931","volume":"26","author":"D Johns","year":"2017","unstructured":"Johns D, Agarwal J, Anderson L, Ying J, Kohlmann W. Breast cancer risk reduction decisions of the BRCA-positive patient: an observational study at a single institution. J Womens Health (Larchmt). 2017;26(6):702\u2013706.","journal-title":"J Womens Health."},{"issue":"2","key":"5976_CR15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1023\/A:1015269620265","volume":"73","author":"LN Lodder","year":"2002","unstructured":"Lodder LN, Frets PG, Trijsburg RW, Meijers-Heijboer EJ, Klijn JG, Seynaeve C, et al. One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery). Breast Cancer Res Treat. 2002;73(2):97-112.","journal-title":"Breast Cancer Res Treat."},{"issue":"5","key":"5976_CR16","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1200\/JCO.2002.20.5.1260","volume":"20","author":"L Scheuer","year":"2002","unstructured":"Scheuer L, Kauff N, Robson M, Kelly B, Barakat R, Satagopan J, et al. Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. J Clin Oncol. 2002;20(5):1260-8.","journal-title":"J Clin Oncol."},{"issue":"3","key":"5976_CR17","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/ijc.20429","volume":"112","author":"R Calderon-Margalit","year":"2004","unstructured":"Calderon-Margalit R, Paltiel O. Prevention of breast cancer in women who carry BRCA1 or BRCA2 mutations: a critical review of the literature. Int J Cancer. 2004;112(3):357-64.","journal-title":"Int J Cancer."},{"issue":"4","key":"5976_CR18","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.amjsurg.2016.06.010","volume":"212","author":"KK Ludwig","year":"2016","unstructured":"Ludwig KK, Neuner J, Butler A, Geurts JL, Kong AL. Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review. Am J Surg. 2016;212(4):660-9.","journal-title":"Am J Surg."},{"issue":"6","key":"5976_CR19","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1200\/JCO.2004.04.188","volume":"22","author":"TR Rebbeck","year":"2004","unstructured":"Rebbeck TR, Friebel T, Lynch HT, Neuhausen SL, van \u2018t Veer L, Garber JE, et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol. 2004;22(6):1055-62.","journal-title":"J Clin Oncol."},{"issue":"3","key":"5976_CR20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJM200107193450301","volume":"345","author":"H Meijers-Heijboer","year":"2001","unstructured":"Meijers-Heijboer H, van Geel B, van Putten WL, Henzen-Logmans SC, Seynaeve C, Menke-Pluymers MB, et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med. 2001;345(3):159-64.","journal-title":"N Engl J Med."},{"issue":"1","key":"5976_CR21","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10549-011-1449-7","volume":"129","author":"SU Dhar","year":"2011","unstructured":"Dhar SU, Cooper HP, Wang T, Parks B, Staggs SA, Hilsenbeck S, et al. Significant differences among physician specialties in management recommendations of BRCA1 mutation carriers. Breast Cancer Res Treat. 2011;129(1):221-7.","journal-title":"Breast Cancer Res Treat."},{"issue":"6","key":"5976_CR22","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1524-4741.2008.00649.x","volume":"14","author":"R Marudanayagam","year":"2008","unstructured":"Marudanayagam R, Singhal R, Tanchel B, O\u2019Connor B, Balasubramanian B, Paterson I. Effect of cavity shaving on reoperation rate following breast-conserving surgery. Breast J. 2008;14(6):570-3.","journal-title":"Breast J."},{"issue":"8","key":"5976_CR23","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/sj.bjc.6604305","volume":"98","author":"AC Antoniou","year":"2008","unstructured":"Antoniou AC, Cunningham AP, Peto J, Evans DG, Lalloo F, Narod SA, et al. The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer. 2008;98(8):1457-66.","journal-title":"Br J Cancer."},{"issue":"2","key":"5976_CR24","first-page":"194","volume":"299","author":"CB Begg","year":"2008","unstructured":"Begg CB, Haile RW, Borg A, Malone KE, Concannon P, Thomas DC, et al. Variation of breast cancer risk among BRCA1\/2 carriers. JAMA. 2008;299(2):194-201.","journal-title":"JAMA."},{"issue":"3","key":"5976_CR25","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.breast.2011.01.006","volume":"20","author":"I Haroun","year":"2011","unstructured":"Haroun I, Graham T, Poll A, Sun P, Hill K, Weitzner E, et al. Reasons for risk-reducing mastectomy versus MRI-screening in a cohort of women at high hereditary risk of breast cancer. Breast. 2011;20(3):254-8.","journal-title":"Breast."},{"issue":"5","key":"5976_CR26","doi-asserted-by":"crossref","first-page":"pii: djv033","DOI":"10.1093\/jnci\/djv033","volume":"107","author":"BA Heemskerk-Gerritsen","year":"2015","unstructured":"Heemskerk-Gerritsen BA, Seynaeve C, van Asperen CJ, Ausems MG, Collee JM, van Doorn HC, et al. Breast cancer risk after salpingo-oophorectomy in healthy BRCA1\/2 mutation carriers: revisiting the evidence for risk reduction. J Natl Cancer Inst. 2015;107(5):pii: djv033.","journal-title":"J Natl Cancer Inst."},{"issue":"1","key":"5976_CR27","doi-asserted-by":"crossref","first-page":"djw177","DOI":"10.1093\/jnci\/djw177","volume":"109","author":"J Kotsopoulos","year":"2017","unstructured":"Kotsopoulos J, Huzarski T, Gronwald J, Singer CF, Moller P, Lynch HT, et al. Bilateral oophorectomy and breast cancer risk in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst. 2017;109(1):djw177.","journal-title":"J Natl Cancer Inst."},{"issue":"12","key":"5976_CR28","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1001\/jamasurg.2014.1081","volume":"149","author":"A Gangi","year":"2014","unstructured":"Gangi A, Cass I, Paik D, Barmparas G, Karlan B, Dang C, et al. Breast cancer following ovarian cancer in BRCA mutation carriers. JAMA Surg. 2014;149(12):1306-13.","journal-title":"JAMA Surg."},{"issue":"3","key":"5976_CR29","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s10689-012-9588-5","volume":"12","author":"JP Gopie","year":"2013","unstructured":"Gopie JP, Mureau MA, Seynaeve C, Ter Kuile MM, Menke-Pluymers MB, Timman R, et al. Body image issues after bilateral prophylactic mastectomy with breast reconstruction in healthy women at risk for hereditary breast cancer. Fam Cancer. 2013;12(3):479-87.","journal-title":"Fam Cancer."},{"issue":"6","key":"5976_CR30","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s11136-015-1181-6","volume":"25","author":"SN Razdan","year":"2016","unstructured":"Razdan SN, Patel V, Jewell S, McCarthy CM. Quality of life among patients after bilateral prophylactic mastectomy: a systematic review of patient-reported outcomes. Qual Life Res. 2016;25(6):1409-21.","journal-title":"Qual Life Res."},{"issue":"16","key":"5976_CR31","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1200\/JCO.2010.29.4041","volume":"29","author":"TA King","year":"2011","unstructured":"King TA, Sakr R, Patil S, Gurevich I, Stempel M, Sampson M, et al. Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. J Clin Oncol. 2011;29(16):2158-64.","journal-title":"J Clin Oncol."},{"issue":"8","key":"5976_CR32","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1245\/s10434-012-2299-1","volume":"19","author":"A Chung","year":"2012","unstructured":"Chung A, Huynh K, Lawrence C, Sim MS, Giuliano A. Comparison of patient characteristics and outcomes of contralateral prophylactic mastectomy and unilateral total mastectomy in breast cancer patients. Ann Surg Oncol. 2012;19(8):2600-6.","journal-title":"Ann Surg Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-017-5976-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-017-5976-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-017-5976-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,11]],"date-time":"2017-09-11T21:30:51Z","timestamp":1505165451000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-017-5976-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,1]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["5976"],"URL":"https:\/\/doi.org\/10.1245\/s10434-017-5976-2","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,1]]}}}